Facebook
Twitter
LinkedIn
Forward
2024 Scottsdale Headache Symposium
Since the inaugural meeting in 1970, the Scottsdale Headache Symposium® continues to be a successful venue for providing practical, clinical, evidence-based information on the diagnosis, management and treatment of patients with headache.
COURSE INSTRUCTIONS:
Live and virtual meeting attendees who joined us in Scottsdale have complimentary access to the recorded content within this course. Please create a VISITOR account using the email address you registered with, or login as a VISITOR using the credentials created during the 65th Annual Scientific Meeting. Once logged in, click "Take Course" to access recorded content, complete the meeting evaluation, and claim CME.
INSTRUCTIONS FOR CLAIMING CME:
- Complete the post-activity evaluation. We suggest you wait to complete the evaluation/claim credit until you’ve watched all recorded sessions for which credit is sought.
- For ABPN Self Assessment Credit, complete the short ABPN Self-Assessment Quiz
- Enter the number of CME credits being claimed per credit type
- Download your certificate (be sure to select AMA credit [MD/DOs] or Participation credit [all others] to access a certificate).
*Please note: The maximum number of credits is calculated based on attending all live and watching all recorded concurrent sessions. Some CME sessions are only offered live and will not be recorded.
Target Audience
The Symposium is designed for general practitioners, internists, pediatricians, neurologists, anesthesiologists, dentists, physical therapists, psychologists, psychiatrists, nurse practitioners, physician assistants, nurses, and other health professionals who treat headache. Education is presented in didactic, case-based, evidence-based, panel and demonstrative formats over the course of four days.
Learning Objectives
At the conclusion of the American Headache Society’s 2024 Scottsdale Headache Symposium, participants will be able to:
- Apply knowledge of the diagnosis, epidemiology, and treatment of headache disorders in adults and children in clinical practice and research
- Discuss controversies and evidence for using CGRP antagonists during pregnancy, in patients with vascular risk factors and as combination therapies
- Incorporate non-pharmacologic treatments in the management of migraine
- Select the appropriate neuroradiological investigations for various secondary headaches
Disclosure Information
The planners and faculty for this activity did not have any relationships to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
PURPOSE/OBJECTIVE
At the conclusion of this program, learners will share that they feel better prepared to manage patients presenting with headache conditions by applying best practices in Headache Medicine retailed to the diagnosis, epidemiology, and treatment of headache disorders in adults and children in clinical practice and research, and will consider the controversies and evidence for using CGRP antagonists during pregnancy, in patients with vascular risk factors and as combination therapies. Learners will report their intention to incorporate non-pharmacologic treatments in the management of migraine & select the appropriate neuroradiological investigations for various secondary headaches.
ACCREDITATION STATEMENT
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The American Headache Society® designates this Other activity (live and recorded sessions) for a maximum of 50.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABPN
THE AMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY HAS REVIEWED THE 2024 SCOTTSDALE HEADACHE SYMPOSIUM AND HAS APPROVED THIS ACTIVITY AS PART OF A COMPREHENSIVE SELF-ASSESSMENT (SA) CME ACTIVITY, WHICH IS MANDATED BY THE ABMS AS A NECESSARY COMPONENT OF CONTINUING CERTIFICATION.
This activity awards up to 50 Category 1 CME which are approved as Self-Assessment credits. The approval period is for November 14, 2024 – June 16, 2025.
AAFP
The AAFP has reviewed 2024 Scottsdale Headache Symposium and deemed it acceptable for up to 26.00 Live AAFP Elective credit(s). Term of Approval is from 11/14/2024 to 11/17/2024. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PHARMACOLOGY
This content has been reviewed for pharmacology hours and the calculated value is: 13.3 hours of pharmacology content.
INSTRUCTIONS FOR CLAIMING CME
- Complete the post-activity evaluation. We suggest you wait to complete the evaluation/claim credit until you’ve watched all recorded sessions for which credit is sought.
- For ABPN Self Assessment Credit, complete the short ABPN Self-Assessment Quiz
- Enter the number of CME credits being claimed per credit type
- Download your certificate (be sure to select AMA credit [MD/DOs] or Participation credit [all others] to access a certificate)
*Please note: The maximum number of credits is calculated based on attending all live and watching all recorded concurrent sessions. Some CME sessions are only offered live and will not be recorded.
FINANCIAL DISCLOSURES
The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
DISCLOSURE OF COMMERCIAL SUPPORT
The American Headache Society® received funding for this activity from the following organizations:
AbbVie Inc.
Eli Lilly and Company
Lundbeck
Pfizer
The American Headache Society received an in-kind donation of migraine units (heads) for the Injection Training Session from the following organizations:
AbbVie Inc.
Available Credit
- 26.00 AAFP
- 50.00 ABPN Self-Assessment
- 50.00 AMA PRA Category 1 Credit™
- 48.25 Participation
